Testing effectiveness (Phase 2)Study completedNCT04626505
What this trial is testing
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
Who this might be right for
Chronic Kidney DiseaseInflammationCardiovascular Risk
Novo Nordisk A/S 36